BG47348A3 - Method for preparing of azitromycin dihydrate - Google Patents

Method for preparing of azitromycin dihydrate

Info

Publication number: BG47348A3
Authority: BG; Bulgaria
Prior art keywords: azitromycin; dihydrate; preparing; sub; tetrahydrofuran
Prior art date: 1987-07-09

Application number

BG084783A

Other languages

Bulgarian (bg)

English (en)

Inventor

Douglas Allen

Kevin Nepveux

Original Assignee

Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-07-09

Filing date

1988-07-05

Publication date

1990-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22202456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG47348(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-07-05 Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware

1990-06-15 Publication of BG47348A3 publication Critical patent/BG47348A3/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Cardiology (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BG084783A 1987-07-09 1988-07-05 Method for preparing of azitromycin dihydrate BG47348A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1987/001612 WO1989000576A1 (en)	1987-07-09	1987-07-09	Azithromycin dihydrate

Publications (1)

Publication Number	Publication Date
BG47348A3 true BG47348A3 (en)	1990-06-15

Family

ID=22202456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG084783A BG47348A3 (en)	1987-07-09	1988-07-05	Method for preparing of azitromycin dihydrate

Country Status (45)

Country	Link
US (1)	US6268489B1 (is)
EP (1)	EP0298650B1 (is)
JP (1)	JPH0631300B2 (is)
KR (1)	KR900006218B1 (is)
CN (1)	CN1016785B (is)
AP (1)	AP44A (is)
AR (1)	AR243532A1 (is)
AT (1)	ATE72446T1 (is)
AU (1)	AU604553B2 (is)
BA (1)	BA98213B1 (is)
BG (1)	BG47348A3 (is)
CA (1)	CA1314876C (is)
CS (1)	CS272241B2 (is)
CY (1)	CY1776A (is)
DD (1)	DD271705A5 (is)
DE (1)	DE3868296D1 (is)
DK (1)	DK172573B1 (is)
EG (1)	EG18527A (is)
ES (1)	ES2038756T3 (is)
FI (1)	FI91263C (is)
GR (1)	GR3003737T3 (is)
HK (1)	HK127594A (is)
HU (1)	HU211862A9 (is)
IE (1)	IE60354B1 (is)
IL (1)	IL86979A (is)
IN (1)	IN168879B (is)
IS (1)	IS1540B (is)
LV (1)	LV10624B (is)
MA (1)	MA21323A1 (is)
MX (1)	MX12213A (is)
MY (1)	MY103744A (is)
NO (1)	NO171556C (is)
NZ (1)	NZ225338A (is)
OA (1)	OA08743A (is)
PH (1)	PH30953A (is)
PL (1)	PL157145B1 (is)
PT (1)	PT87933B (is)
RO (1)	RO107257B1 (is)
RU (1)	RU2066324C1 (is)
SG (1)	SG27794G (is)
SI (1)	SI8811325A8 (is)
UA (1)	UA27040C2 (is)
WO (1)	WO1989000576A1 (is)
YU (1)	YU45075B (is)
ZA (1)	ZA884925B (is)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20020231A2 (en) *	2002-03-18	2003-12-31	Pliva D D	ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US5912331A (en) *	1991-03-15	1999-06-15	Merck & Co., Inc.	Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) *	1992-03-26	1999-11-16	Merck & Co., Inc.	Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) *	1992-04-02	1993-02-23	Merck & Co., Inc.	8a-AZA-8a-homoerythromycin cyclic iminoethers
CA2081268A1 (en) *	1991-10-25	1993-04-26	Katsuhiro Imaki	Glycine derivative monosodium salt tetrahydrate
US5215980A (en) *	1992-01-17	1993-06-01	Merck & Co., Inc.	10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) *	1992-08-26	1993-05-11	Merck & Co., Inc.	Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) *	1993-04-14	1994-07-26	Merck & Co., Inc.	Process of producing 8A- and 9A-azalide antibiotics
CN1034734C (zh) *	1993-12-10	1997-04-30	北京市集才药物研究所	一种新的阿齐红霉素结晶及其制备方法
US5605889A (en)	1994-04-29	1997-02-25	Pfizer Inc.	Method of administering azithromycin
PT758244E (pt)	1994-05-06	2002-04-29	Pfizer	Formas de dosagem libertacao controlada de azitromicina
ES2122905B1 (es) *	1996-07-11	1999-11-16	Astur Pharma Sa	Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
SI1036083T1 (en) *	1997-10-16	2004-10-31	Pliva-Istra�iva�ki institut d.o.o.	Novel 9a-azalides
US6861411B1 (en)	1997-12-02	2005-03-01	Pfizer, Inc.	Method of treating eye infections with azithromycin
PT102130A (pt) *	1998-03-13	1999-09-30	Hovione Sociedade Quimica S A	Processo de preparacao de dihidrato de azitromicina
TW546302B (en) *	1998-05-08	2003-08-11	Biochemie Sa	Improvements in macrolide production
CA2245398C (en)	1998-08-21	2002-01-29	Apotex Inc.	Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
PT1152765E (pt)	1998-11-30	2004-12-31	Teva Pharma	Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem
US7056893B2 (en)	1999-03-31	2006-06-06	Insite Vision, Inc.	Topical treatment for prevention of ocular infections
US6239113B1 (en)	1999-03-31	2001-05-29	Insite Vision, Incorporated	Topical treatment or prevention of ocular infections
BR0011300A (pt) *	1999-05-18	2002-02-26	Pfizer Prod Inc	Formas cristalinas de um antibiótico macrólido
EP1712556B1 (en) *	1999-06-29	2010-06-02	Sandoz AG	Azithromycin monohydrate
ES2177373B1 (es)	1999-11-26	2003-11-01	Astur Pharma Sa	Preparacion de azitromicina en su forma no cristalina
AU2928701A (en)	2000-01-04	2001-07-16	Teva Pharmaceutical Industries Ltd.	Preparation method of azithromycin dihydrate
ES2162764B1 (es) *	2000-05-17	2003-04-01	Ercros Ind Sa	Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
WO2002010144A1 (es)	2000-07-25	2002-02-07	Laboratorio Silanes, S.A. De C.V.	PROCESO PARA LA PREPARACION EN UN SOLO PASO DE 7,16-DIOXA-2-AZA-10-O-CLADINOSIL-12-O-DESOSAMINIL-4,5-DIHIDROXI-6-ETIL-3,5,9,11,13,15-HEXAMETILBICICLO[11.2.1]HEXADECA-1(2)-EN-8-ONA Y OBTENCION DE UNA FORMA NUEVA DE 9-DESOXO-9a-AZA-9a-METIL-9a-HOMOERITROMICINA A
ES2172417B1 (es) *	2000-07-31	2003-09-16	Sint Quimica Sa	Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
ATE306491T1 (de) *	2000-08-23	2005-10-15	Wockhardt Ltd	Verfahren zur herstellung von wasserfreiem azithromycin
AU2002221895A1 (en) *	2000-11-27	2002-06-03	Biochemie S.A.	Macrolide solvates
IN190080B (is) *	2001-01-29	2003-06-07	Alembic Ltd
KR100491183B1 (ko)	2001-03-21	2005-05-25	한미약품 주식회사	아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
EP1652851A1 (en)	2001-05-22	2006-05-03	Pfizer Products Inc.	New crystal form of Azithromycin
US6861413B2 (en)	2001-05-22	2005-03-01	Pfizer Inc.	Stable non-dihydrate azithromycin oral suspensions
JP2004530703A (ja)	2001-05-22	2004-10-07	ファイザー・プロダクツ・インク	結晶形アジスロマイシン
EA200400214A1 (ru) *	2001-08-21	2004-06-24	Пфайзер Продактс Инк.	Азитромицин в виде разовой дозы
MXPA04005105A (es) *	2001-12-21	2004-08-19	Pfizer Prod Inc	Formulaciones de acitromicina directamente compresibles.
EP1455757A2 (en) *	2001-12-21	2004-09-15	Pfizer Products Inc.	Methods for wet granulating azithromycin
MXPA04007427A (es) *	2002-02-01	2004-10-11	Pfizer Prod Inc	Formulaciones de azitromicina granuladas por via seca.
US7376064B2 (en)	2002-02-25	2008-05-20	Samsung Electronics Co., Ltd.	Method and apparatus for recording data on optical recording medium
ITMI20021209A1 (it) *	2002-06-04	2003-12-04	Chemi Spa	Processo di preparazione di azitromicina ad elevata purezza
US6855813B2 (en) *	2002-07-19	2005-02-15	Alembic Limited	Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en)	2002-07-22	2004-06-30	PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o.	Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB2395482A (en) *	2003-07-03	2004-05-26	Jubilant Organosys Ltd	Process for preparing non-hygroscopic azithromycin dihydrate
US20050013835A1 (en) *	2003-07-15	2005-01-20	Pfizer Inc.	Stable non-dihydrate azithromycin oral suspensions
EP1694304A2 (en) *	2003-12-04	2006-08-30	Pfizer Products Inc.	Azithromycin multiparticulate dosage forms by liquid-based processes
US6984403B2 (en) *	2003-12-04	2006-01-10	Pfizer Inc.	Azithromycin dosage forms with reduced side effects
JP2007513143A (ja) *	2003-12-04	2007-05-24	ファイザー・プロダクツ・インク	押出機を使用して好ましくはポロクサマーおよびグリセリドを含む多粒子アジスロマイシン組成物を製造するための噴霧凝固法
AU2004294817B2 (en) *	2003-12-04	2007-01-25	Pfizer Products Inc.	Method for making pharmaceutical multiparticulates
WO2005053652A1 (en)	2003-12-04	2005-06-16	Pfizer Products Inc.	Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
JP2007513139A (ja) *	2003-12-04	2007-05-24	ファイザー・プロダクツ・インク	安定性の改善した多粒子組成物
WO2005053639A2 (en) *	2003-12-04	2005-06-16	Pfizer Products Inc.	Controlled release multiparticulates formed with dissolution enhancers
EP1689368B1 (en) *	2003-12-04	2016-09-28	Bend Research, Inc	Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions
US7468428B2 (en) *	2004-03-17	2008-12-23	App Pharmaceuticals, Llc	Lyophilized azithromycin formulation
US20060116336A1 (en) *	2004-03-17	2006-06-01	American Pharmaceutical Partners, Inc.	Lyophilized azithromycin formulation
WO2006011160A1 (en)	2004-06-28	2006-02-02	Alembic Limited	Process for the preparation of azithromycin monohydrate isopropanol clathrate
CN1308361C (zh) *	2004-08-09	2007-04-04	大连振邦氟涂料股份有限公司	乙烯－三氟氯乙烯共聚物的制备方法
US7683162B2 (en) *	2004-08-30	2010-03-23	Taro Pharmaceutical Industries Limited	Process of preparing a crystalline azithromycin monohydrate
MX2007005221A (es) *	2004-12-01	2007-06-22	Teva Gyogyszergyar Zartkoeruen	Formas cristalinas de ascomicina y preparacion de ellas.
CA2591923A1 (en) *	2004-12-21	2006-06-29	Pfizer Products Inc.	Enteric coated azithromycin multiparticulates
US8546423B2 (en)	2005-05-18	2013-10-01	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
CN100366686C (zh) *	2006-01-12	2008-02-06	济南瑞氟化工科技有限公司	一种氟硅超双疏不粘涂料
US20070281894A1 (en) *	2006-06-05	2007-12-06	Auspex Pharmaceuticals, Inc.	Preparation and utility of substituted erythromycin analogs
US7704959B2 (en)	2006-10-03	2010-04-27	Dow Pharmaceutical Sciences	Azithromycin for the treatment of nodular acne
US20090062220A1 (en) *	2007-08-29	2009-03-05	Protia, Llc	Deuterium-enriched azithromycin
CN101177441B (zh) *	2007-12-05	2012-05-23	浙江耐司康药业有限公司	一种稳定的阿奇霉素一水合物结晶的制备方法
CN101624412B (zh)	2008-07-10	2012-07-04	刘力	大环内酯类衍生物及其制备和用途
US8629139B2 (en)	2008-10-07	2014-01-14	Mpex Pharmaceuticals, Inc.	Topical use of Levofloxacin for reducing lung inflammation
NZ592717A (en)	2008-10-07	2013-03-28	Mpex Pharmaceuticals Inc	Aerosol fluoroquinolone formulations for improved pharmacokinetics comprising levofloxacin or ofloxacin and a di- or trivalent cation
CN101418026B (zh) *	2008-10-09	2011-05-18	南京工业大学	一种晶型和粒度可控的阿奇霉素结晶工艺
CN101787063B (zh) *	2009-01-23	2012-12-19	刘力	抗感染药物及其制备和用途
KR20120004448A (ko)	2009-03-13	2012-01-12	다 볼떼라	그람음성 박테리아 제거용 조성물 및 방법
PT2473170T (pt)	2009-09-04	2019-08-23	Horizon Orphan Llc	Utilização de levofloxacina em aerossol para tratamento de fibrose cística
CN102911219A (zh) *	2011-08-03	2013-02-06	山东方明药业集团股份有限公司	一种阿齐霉素在水相直接结晶的方法
CN103159811A (zh) *	2011-12-10	2013-06-19	山东方明药业集团股份有限公司	一种阿齐霉素中间体9a-脱氧-9a-氮杂-9a-高红霉素A的制备方法
WO2013088274A1 (en)	2011-12-14	2013-06-20	Wockhardt Limited	Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN102417531B (zh) *	2011-12-20	2014-06-11	浙江国邦药业有限公司	一种阿奇霉素一水合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4020270A (en) *	1974-05-02	1977-04-26	Societa' Farmaceutici Italia S.P.A.	L-lyxohex-1-enopyranose derivative
US4219641A (en) *	1979-06-14	1980-08-26	The Upjohn Company	Process for preparing erythromycin succinate
YU43006B (en)	1981-03-06	1989-02-28	Pliva Pharm & Chem Works	Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) *	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) *	1982-11-15	1986-03-04	Pfizer	Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4526889A (en) *	1982-11-15	1985-07-02	Pfizer Inc.	Epimeric azahomoerythromycin A derivative, intermediates and method of use
US4512982A (en) *	1984-04-13	1985-04-23	Pfizer Inc.	9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
YU43402B (en) *	1985-03-04	1989-06-30	Pliva Pharm & Chem Works	Process for preparation of 11-aza-10-deoxo-10-dihydroeritromycin "a" by using electro-chemical reduction
WO1989002271A1 (en)	1987-09-10	1989-03-23	Pfizer	Azithromycin and derivatives as antiprotozoal agents

1987
- 1987-07-09 WO PCT/US1987/001612 patent/WO1989000576A1/en active IP Right Grant
- 1987-07-09 MX MX1221388A patent/MX12213A/es unknown
- 1987-07-09 UA UA93004522A patent/UA27040C2/uk unknown
- 1987-07-09 RO RO143593A patent/RO107257B1/ro unknown
- 1987-07-09 RU SU874742955A patent/RU2066324C1/ru active
1988
- 1988-05-11 IN IN418/DEL/88A patent/IN168879B/en unknown
- 1988-06-15 AP APAP/P/1988/000093A patent/AP44A/en active
- 1988-06-28 ES ES198888305921T patent/ES2038756T3/es not_active Expired - Lifetime
- 1988-06-28 AT AT88305921T patent/ATE72446T1/de not_active IP Right Cessation
- 1988-06-28 DE DE8888305921T patent/DE3868296D1/de not_active Expired - Lifetime
- 1988-06-28 EP EP88305921A patent/EP0298650B1/en not_active Expired - Lifetime
- 1988-07-04 IL IL86979A patent/IL86979A/xx not_active IP Right Cessation
- 1988-07-05 MY MYPI88000744A patent/MY103744A/en unknown
- 1988-07-05 BG BG084783A patent/BG47348A3/xx unknown
- 1988-07-06 CS CS884896A patent/CS272241B2/cs not_active IP Right Cessation
- 1988-07-06 JP JP63168637A patent/JPH0631300B2/ja not_active Expired - Lifetime
- 1988-07-07 CA CA000571381A patent/CA1314876C/en not_active Expired - Lifetime
- 1988-07-07 IS IS3370A patent/IS1540B/is unknown
- 1988-07-07 EG EG376/88A patent/EG18527A/xx active
- 1988-07-07 DD DD88317672A patent/DD271705A5/de unknown
- 1988-07-07 PH PH37189A patent/PH30953A/en unknown
- 1988-07-07 PT PT87933A patent/PT87933B/pt not_active IP Right Cessation
- 1988-07-07 AR AR88311356A patent/AR243532A1/es active
- 1988-07-07 PL PL1988273590A patent/PL157145B1/pl unknown
- 1988-07-08 ZA ZA884925A patent/ZA884925B/xx unknown
- 1988-07-08 OA OA59384A patent/OA08743A/xx unknown
- 1988-07-08 DK DK198803806A patent/DK172573B1/da not_active IP Right Cessation
- 1988-07-08 KR KR1019880008463A patent/KR900006218B1/ko not_active IP Right Cessation
- 1988-07-08 YU YU1325/88A patent/YU45075B/xx unknown
- 1988-07-08 NZ NZ225338A patent/NZ225338A/xx unknown
- 1988-07-08 IE IE210888A patent/IE60354B1/en not_active IP Right Cessation
- 1988-07-08 AU AU18839/88A patent/AU604553B2/en not_active Expired
- 1988-07-08 CN CN88104331A patent/CN1016785B/zh not_active Expired
- 1988-07-08 SI SI8811325A patent/SI8811325A8/sl unknown
- 1988-07-11 MA MA21565A patent/MA21323A1/fr unknown
1990
- 1990-01-08 FI FI900087A patent/FI91263C/fi not_active IP Right Cessation
- 1990-01-08 NO NO90900077A patent/NO171556C/no not_active IP Right Cessation
1992
- 1992-02-06 GR GR920400067T patent/GR3003737T3/el unknown
- 1992-12-21 US US07/994,040 patent/US6268489B1/en not_active Expired - Lifetime
1993
- 1993-11-17 LV LVP-93-1240A patent/LV10624B/xx unknown
1994
- 1994-02-22 SG SG27794A patent/SG27794G/en unknown
- 1994-11-17 HK HK127594A patent/HK127594A/xx not_active IP Right Cessation
1995
- 1995-06-30 HU HU95P/P00738P patent/HU211862A9/hu unknown
- 1995-10-20 CY CY177695A patent/CY1776A/xx unknown
1998
- 1998-03-30 BA BA980213A patent/BA98213B1/bs active

Also Published As

Publication number	Publication date
RU2066324C1 (ru)	1996-09-10
MX12213A (es)	1993-05-01
FI91263B (fi)	1994-02-28
DK172573B1 (da)	1999-01-25
AP8800093A0 (en)	1988-05-01
AU604553B2 (en)	1990-12-20
FI900087A (fi)	1990-01-08
US6268489B1 (en)	2001-07-31
EP0298650A2 (en)	1989-01-11
NO171556C (no)	1993-03-31
PL273590A1 (en)	1989-03-20
HK127594A (en)	1994-11-25
LV10624A (lv)	1995-04-20
JPH0631300B2 (ja)	1994-04-27
YU132588A (en)	1990-02-28
HU211862A9 (en)	1995-12-28
IE882108L (en)	1989-01-09
KR890002137A (ko)	1989-04-08
MY103744A (en)	1993-09-30
CS489688A2 (en)	1990-03-14
SI8811325A8 (en)	1996-12-31
IE60354B1 (en)	1994-06-29
ATE72446T1 (de)	1992-02-15
AU1883988A (en)	1989-01-12
EG18527A (en)	1993-10-30
IS1540B (is)	1994-01-28
CN1030422A (zh)	1989-01-18
WO1989000576A1 (en)	1989-01-26
CA1314876C (en)	1993-03-23
YU45075B (en)	1991-08-31
NZ225338A (en)	1990-02-26
PT87933A (pt)	1989-06-30
IL86979A (en)	1992-11-15
CS272241B2 (en)	1991-01-15
CY1776A (en)	1995-10-20
DE3868296D1 (de)	1992-03-19
ZA884925B (en)	1990-02-28
IL86979A0 (en)	1988-12-30
EP0298650B1 (en)	1992-02-05
PT87933B (pt)	1994-09-30
IS3370A7 (is)	1989-01-10
BA98213B1 (bs)	1999-08-02
KR900006218B1 (ko)	1990-08-25
AR243532A1 (es)	1993-08-31
EP0298650A3 (en)	1989-11-08
PL157145B1 (en)	1992-04-30
DK380688D0 (da)	1988-07-08
RO107257B1 (ro)	1993-10-30
NO171556B (no)	1992-12-21
NO900077L (no)	1990-01-08
PH30953A (en)	1997-12-23
MA21323A1 (fr)	1989-04-01
NO900077D0 (no)	1990-01-08
CN1016785B (zh)	1992-05-27
JPS6438096A (en)	1989-02-08
ES2038756T3 (es)	1993-08-01
AP44A (en)	1989-07-27
DD271705A5 (de)	1989-09-13
SG27794G (en)	1994-10-14
IN168879B (is)	1991-06-29
FI900087A0 (fi)	1990-01-08
FI91263C (fi)	1994-06-10
UA27040C2 (uk)	2000-02-28
GR3003737T3 (is)	1993-03-16
OA08743A (fr)	1989-03-31
DK380688A (da)	1989-01-10
LV10624B (en)	1995-10-20

Publication	Publication Date	Title
BG47348A3 (en)	1990-06-15	Method for preparing of azitromycin dihydrate
ATE92452T1 (de)	1993-08-15	Waesserige, silane enthaltende systeme zum wasserabweisendmachen von maueroberflaechen.
FI945451A0 (fi)	1994-11-21	Makeutusaineina käytettäviä yhdisteitä sekä menetelmä niiden valmistamiseksi
UA7228A1 (uk)	1995-06-30	Спосіб одержання похідних n-(4-індолілпіперідиноалкіл )бензімідазолону або їх солей з кислотами
ES476919A1 (es)	1979-12-16	Procedimiento para la preparacion de nuevos compuestos de 2-pirrolidona.
ES8507569A1 (es)	1985-09-01	Un procedimiento de transformar un compuesto de teicoplanina, o un compuesto del tipo de teicoplanina, en desglucoteicoplanina
BG41126A3 (en)	1987-04-15	Method for preparing benzamides
YU46699B (sh)	1994-04-05	Kristalni monohidratni oblik 1-karbacefalosporina
UA6022A1 (uk)	1994-12-29	СПОСІБ ОТРИМАННЯ ЦИКЛОАЛКОМЕДІВ (8-beta)-1АЛКІЛ-6-(ЗАМІЩЕНОГО) ЕРГОЛІНУ АБО ЇХ ФАРМАЦЕВТИЧНО ПРИДАТНИХ КИСЛОТНО-АДИТИВНИХ СОЛЕЙ
FI841886A (fi)	1984-11-13	Vid detektering av ioner anvaendbar ny foerening och foerfarande foer dess framstaellning.
ES542745A0 (es)	1986-04-16	Un procedimiento para preparar derivados de acido neuramini-co
PT86619A (pt)	1988-02-01	Process for preparing alkylmelatonins
PT80791A (fr)	1985-08-01	Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres
BG37225A3 (en)	1985-04-15	Method for preparing ammonia salts of substituted carbonic acid
JPS5212109A (en)	1977-01-29	Process for preparation of alkylglycerylether
IT8721697A0 (it)	1987-08-24	Derivati dell'acido 7-ossabiciclo (2.2.1.) eptan idrossammico utili come inibitori duplici
JPS5225740A (en)	1977-02-25	Preparation of o-acyl-amidinophenols or acid addition salts thereof
FR2603580B1 (fr)	1990-05-25	Procede de preparation d'un compose organique polyfluorure
TW330205B (en)	1998-04-21	A process for preparing loracarbef monohydrate
BG31501A3 (en)	1982-01-15	Method for obtaining of 3- arjl- isoxazol- 5- il- benzene carbonic acid and its salts
FR2489172B1 (fr)	1985-08-23	Procede de preparation d'un produit tensio-actif pompable a base de polyether-acide acetique
FR2356658A1 (fr)	1978-01-27	Procede de production d'acides phosphinico-carboxyliques aliphatiques substitues
ES8707709A1 (es)	1987-08-16	Un procedimiento para producir derivados cristalinos de acido 3-acil o haloacil-amino-4-trimetilaminobutilico
DK578083D0 (da)	1983-12-15	Antibiotika benaevnt a51568 faktor a og b og fremgangsmaade til fremstilling heraf
MY110724A (en)	1999-01-30	Process for converting loracarbef dihydrate to loracarbef monohydrate